Human papillomavirus vaccination uptake and determinant factors among adolescent schoolgirls in sub-Saharan Africa: A systematic review and meta-analysis

Hum Vaccin Immunother. 2024 Dec 31;20(1):2326295. doi: 10.1080/21645515.2024.2326295. Epub 2024 Mar 20.

Abstract

Despite the ongoing global vaccination campaign aimed at preventing human papillomavirus (HPV) related health issues, the uptake of the HPV vaccine remains unacceptably low in developing regions, particularly in sub-Saharan Africa (SSA). Therefore, this systematic review and meta-analysis aimed at determining the pooled prevalence and associated factors of HPV vaccine uptake among adolescent school girls in SSA. Electronic bio-medical databases were explored. Pooled prevalence, publication bias, meta-regression, sub-group, and sensitivity analysis were performed. The estimated pooled prevalence of HPV vaccine uptake was 28.53% [95% CI: (5.25, 51.81)]. Having good knowledge and a positive attitude was significantly associated with HPV vaccine uptake in SSA. Subgroup analysis revealed the highest uptake was 62.52% from Kenya and the lowest was 3.77% in Nigeria. The HPV vaccine uptake is low. It underscores the need for community education, school-based immunization, and education programs that promote the uptake of the vaccine to increase coverage.

Keywords: Uptake; adolescent; human papilloma virus vaccine; meta-analysis; sub-Saharan Africa; systematic review.

Publication types

  • Meta-Analysis
  • Systematic Review
  • Review

MeSH terms

  • Adolescent
  • Africa South of the Sahara / epidemiology
  • Female
  • Human Papillomavirus Viruses
  • Humans
  • Papillomavirus Infections*
  • Papillomavirus Vaccines*
  • Uterine Cervical Neoplasms*
  • Vaccination

Substances

  • Papillomavirus Vaccines

Grants and funding

This study did not receive any specific grant from any organization in either the public or commercial sector.